Cargando…
MNRR1 is a driver of ovarian cancer progression
Cancer progression requires the acquisition of mechanisms that support proliferative potential and metastatic capacity. MNRR1 (also CHCHD2, PARK22, AAG10) is a bi-organellar protein that in the mitochondria can bind to Bcl-xL to enhance its anti-apoptotic function, or to respiratory chain complex IV...
Autores principales: | Chehade, Hussein, Purandare, Neeraja, Fox, Alexandra, Adzibolosu, Nicholas, Jayee, Shawn, Singh, Aryan, Tedja, Roslyn, Gogoi, Radhika, Aras, Siddhesh, Grossman, Lawrence I., Mor, Gil, Alvero, Ayesha B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860385/ https://www.ncbi.nlm.nih.gov/pubmed/36641875 http://dx.doi.org/10.1016/j.tranon.2023.101623 |
Ejemplares similares
-
MNRR1, a Biorganellar Regulator of Mitochondria
por: Grossman, Lawrence I., et al.
Publicado: (2017) -
Regulatory Role of the Adipose Microenvironment on Ovarian Cancer Progression
por: Chehade, Hussein, et al.
Publicado: (2022) -
Generation of Stable Epithelial–Mesenchymal Hybrid Cancer Cells with Tumorigenic Potential
por: Tedja, Roslyn, et al.
Publicado: (2023) -
Mitochondria Autoimmunity and MNRR1 in Breast Carcinogenesis: A Review
por: Madrid, Félix Fernández, et al.
Publicado: (2020) -
Lipopolysaccharide induces placental mitochondrial dysfunction in murine and human systems by reducing MNRR1 levels via a TLR4-independent pathway
por: Purandare, Neeraja, et al.
Publicado: (2022)